Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112849 · ClinicalTrials.gov registry record
Electronic S3 Prediction of Hospital Readmissions for HF Exacerbation
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 28
- Enrollment target
NCT04112849: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT04112849 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04112849 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The study objective is to measure the value of the third heart sound (S3) for the prediction of recurrent heart failure (HF). For the purpose of this study, a heart failure event will be defined as a hospitalization with a primary diagnosis of heart failure. The main hypothesis of the study is that measurement of S3, using a microelectronic machine microphone positioned in a wearable device (Nanowear Wearable Congestive Heart Failure Management System) near the time of discharge from a hospitalization for heart failure, can predict which patients will be at high risk for a heart failure event, thereby identifying a group in whom increased surveillance and monitoring may decrease hospital readmissions for worsening heart failure.
Primary Outcome
Total hospitalizations will be monitored from time patient is initially discharged for acute heart failure until 90 days post-discharge.
Interventions
- DIAGNOSTIC_TEST Measurement of S3 heart sound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-03-11 |
| Est. Completion | 2022-09-01 |
What the finished NCT04112849 record still lists
NCT04112849 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Measurement of S3 heart sound is the first listed.
NCT04112849 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04112849 about?
NCT04112849 is a clinical study titled "Electronic S3 Prediction of Hospital Readmissions for HF Exacerbation". The study objective is to measure the value of the third heart sound (S3) for the prediction of recurrent heart failure (HF). For the purpose of this study, a heart failure event will be defined as a hospitalization with a primary diagnosis of heart failure. The main hypothesis of the study is that ...
What is the current status of trial NCT04112849?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2020-03-11. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT04112849?
The interventions under investigation include: Measurement of S3 heart sound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04112849?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI